Abstract
A significant percentage of the human population does not respond well to commercially available recombinant Hepatitis B Virus (HBV) surface vaccine. So it must be replaced by modified vaccines. A chimeric protein comprising both the core and surface portions of the viral envelope was designed on the premise that if the HBV surface protein is fused with the core protein of the viral envelope, it can produce B-cell as well as T-cell immune response. A 23 kDa molecular weight protein, comprising 216 amino acids and consisting of the core and surface regions of the viral envelope protein, was designed. NNPREDICT and PSIPRED programs have provided the secondary structure elements of the protein. The tertiary structure of the protein was predicted by the use of 3D-JIGSAW program. In the predicted tertiary structure, α-helices form a helical bundle domain and the β-strands form another separate domain.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Bioscience, Biochemistry and Bioinformatics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
